An Effective Medication With a Serious Side Effect

Gentamicin is a powerful antibiotic used for treating severe bacterial infections. However, this medication carries a significant risk of damage to the inner ear, a condition known as ototoxicity. While gentamicin can affect hearing, its most devastating impact is often on the vestibular system, which controls balance. The result can be a permanent and disabling bilateral vestibulopathy, profoundly altering a person’s quality of life.

Why Gentamicin Damages the Inner Ear

Gentamicin molecules are taken up by the sensory hair cells of the inner ear. The drug disrupts cellular metabolism and generates free radicals, ultimately causing hair cell death. The vestibular hair cells, particularly those in the cristae of the semicircular canals, are especially vulnerable. Because the toxin typically damages both ears, patients frequently develop bilateral vestibular loss. The damaged tissue does not regenerate, meaning the resulting vestibulopathy is often irreversible.

The Hallmark Symptoms of Gentamicin Ototoxicity

Patients who experience gentamicin-induced vestibular toxicity present with a cluster of unmistakable symptoms. Unlike a sudden viral infection that produces vivid rotatory vertigo, gentamicin toxicity can develop more subtly, although some patients do experience an acute phase with a sensation that the world is spinning, known as rotatory vertigo. More commonly, the principal complaints are persistent dizziness (often described as a swaying or floating feeling rather than true spinning), unsteadiness, and a general sense of imbalance.

Because the loss of vestibular input is bilateral, the brain cannot compensate using signals from the other ear. This leads to a debilitating condition where patients feel constant instability. A cardinal feature is oscillopsia, the illusion that the visual world is bouncing or jumping as the patient walks or moves their head. Attempting to read a sign or recognise a face while walking can become nearly impossible. Walking on uneven surfaces or in the dark, where visual and proprioceptive clues cannot compensate, is particularly difficult. Patients often report a frozen, unsteady gait that qualifies as true ataxia, making them vulnerable to falls.

Hearing Loss and Other Auditory Effects

Although the vestibular apparatus is the primary target, gentamicin can also harm the cochlea. Hearing loss caused by gentamicin typically begins in the high frequencies and may progress to affect speech understanding. This hearing impairment can be unilateral or bilateral, and it may appear after the balance problems have stabilised. Tinnitus, a ringing or buzzing in the ears, may accompany the hearing loss. Some patients experience pressure or fullness in the ear as well. The combination of bilateral vestibular hypofunction and high-frequency hearing loss can be particularly isolating.

Diagnosing the Condition

A diagnosis of gentamicin-induced vestibulopathy requires a careful history of medication use, a clinical neurological examination, and specialised testing. Instrumented testing such as video head impulse testing and caloric tests can reveal symmetrically reduced or absent vestibular responses in both ears, confirming bilateral involvement. Audiometry is used to assess hearing thresholds. The diagnosis is essentially clinical, relying heavily on the temporal relationship between gentamicin exposure and the onset of imbalance and oscillopsia.

Living With Bilateral Vestibulopathy

There is currently no cure for the hair cell damage caused by gentamicin. Management focuses on rehabilitation and safety. Vestibular rehabilitation therapy, which involves balance exercises and gaze stabilisation drills, may help the brain use remaining sensory information more effectively, reducing unsteadiness and dizziness. Because the condition is permanent, patients must adopt safety strategies to prevent falls, such as avoiding dark, uneven terrain and using supportive aids when needed. While some patients recover partial function over time through central adaptation, others are left with permanent imbalance and ataxia that require lifelong adjustments. Preventing ototoxicity in the first place is therefore critical: gentamicin should be used judiciously, at the lowest effective dose, and with close monitoring of kidney function and drug levels whenever feasible.